DE69435103D1 - Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung - Google Patents
Methode zur Bildung einer subtrahierten cDNA Bank und ihre VerwendungInfo
- Publication number
- DE69435103D1 DE69435103D1 DE69435103T DE69435103T DE69435103D1 DE 69435103 D1 DE69435103 D1 DE 69435103D1 DE 69435103 T DE69435103 T DE 69435103T DE 69435103 T DE69435103 T DE 69435103T DE 69435103 D1 DE69435103 D1 DE 69435103D1
- Authority
- DE
- Germany
- Prior art keywords
- stranded
- double
- cdna library
- subtracted
- cdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002299 complementary DNA Substances 0.000 title abstract 10
- 108020004414 DNA Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/143,576 US5643761A (en) | 1993-10-27 | 1993-10-27 | Method for generating a subtracted cDNA library and uses of the generated library |
US08/316,537 US6051376A (en) | 1994-09-30 | 1994-09-30 | Uses of mda-6 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69435103D1 true DE69435103D1 (de) | 2008-07-10 |
Family
ID=26841189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69435103T Expired - Lifetime DE69435103D1 (de) | 1993-10-27 | 1994-10-24 | Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung |
Country Status (10)
Country | Link |
---|---|
US (4) | US6720408B2 (de) |
EP (3) | EP0730659A4 (de) |
JP (2) | JP4145953B2 (de) |
KR (1) | KR100355111B1 (de) |
AT (1) | ATE397066T1 (de) |
AU (1) | AU695540B2 (de) |
CA (1) | CA2174354C (de) |
DE (1) | DE69435103D1 (de) |
DK (1) | DK1650303T3 (de) |
WO (1) | WO1995011986A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2170641C (en) * | 1993-08-30 | 2011-11-15 | James R. Smith | Senescent cell-derived inhibitors of dna synthesis |
DE69435103D1 (de) * | 1993-10-27 | 2008-07-10 | Univ Columbia | Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung |
EP0783317B1 (de) * | 1994-05-24 | 2004-11-24 | Baylor College Of Medicine | Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese |
US5710137A (en) | 1996-08-16 | 1998-01-20 | The Trustees Of Columbia University In The City Of New York | Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype |
JP2001508652A (ja) * | 1996-12-23 | 2001-07-03 | シェーリング コーポレイション | Il10に関連する哺乳動物サイトカイン |
US6071696A (en) * | 1996-12-30 | 2000-06-06 | The Trustees Of Columbia University In The City Of New York | Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation |
US6190909B1 (en) * | 1997-04-17 | 2001-02-20 | Millennium Pharmaceuticals, Inc. | TH2-specific gene |
US6399334B1 (en) * | 1997-09-24 | 2002-06-04 | Invitrogen Corporation | Normalized nucleic acid libraries and methods of production thereof |
US6432707B1 (en) | 1997-12-24 | 2002-08-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6379951B1 (en) | 1997-12-24 | 2002-04-30 | Corixa Corporation | Compounds for immunotherapy of breast cancer and methods for their use |
US6410507B1 (en) | 1997-12-24 | 2002-06-25 | Corixa Corporation | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
EP1042360A2 (de) * | 1997-12-24 | 2000-10-11 | Corixa Corporation | Zusammensetzungen für immunotherapie und diagnose von brustkrebs und verfahren für ihre verwendung |
AU2343399A (en) * | 1998-01-26 | 1999-08-09 | Genquest Inc. | Differentiation-associated sequences and methods of use therefor |
WO1999037774A2 (en) * | 1998-01-26 | 1999-07-29 | Genquest, Inc. | Differentiation-associated sequences and methods of use therefor |
US6413717B1 (en) * | 1998-03-18 | 2002-07-02 | Corixa Corporation | Methods for indentifying anti-cancer agents |
WO1999060124A2 (en) * | 1998-05-15 | 1999-11-25 | Fei Huang | Differentiation-associated sequences and methods of use therefor |
US6468758B1 (en) | 1998-09-23 | 2002-10-22 | Corixa Corporation | Compositions and methods for ovarian cancer therapy and diagnosis |
AU2342900A (en) * | 1998-09-23 | 2000-05-01 | Cleveland Clinic Foundation, The | Novel interferon stimulated and repressed genes |
EP1307234B1 (de) * | 1999-07-15 | 2008-04-02 | Introgen Therapeutics, Inc. | Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 |
AU2001231192A1 (en) * | 2000-01-26 | 2001-08-07 | Vanderbilt University | Mob-5/hmob-5 as a cancer diagnostic marker |
DE10003653A1 (de) * | 2000-01-28 | 2001-08-09 | Thorsten Petrich | Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen |
US6841362B1 (en) | 2000-02-29 | 2005-01-11 | The Trustees Of Columbia University In The City Of New York | Melanoma differentiation associated gene-7 promoter and uses thereof |
US7229822B1 (en) | 2000-02-29 | 2007-06-12 | Univ Columbia | Melanoma differentation associated gene-5 and vectors and cells containing same |
EP1404359A2 (de) * | 2000-12-07 | 2004-04-07 | Board Of Regents, The University Of Texas System | Behandlungsverfahren mit menschlichem mda-7 |
US8008459B2 (en) | 2001-01-25 | 2011-08-30 | Evolva Sa | Concatemers of differentially expressed multiple genes |
US7838287B2 (en) | 2001-01-25 | 2010-11-23 | Evolva Sa | Library of a collection of cells |
US6902930B2 (en) | 2001-08-29 | 2005-06-07 | Vanderbilt University | Human Mob-5 (IL-24) receptors and uses thereof |
CA2480176A1 (en) | 2002-04-11 | 2003-10-23 | Zymogenetics, Inc. | Use of interleukin-24 to treat ovarian cancer |
AU2003274963A1 (en) * | 2002-12-23 | 2004-07-29 | The Trustees Of Columbia University In The City Of New York | Mda-7 and free radicals in the treatment of cancer |
WO2005082396A2 (en) | 2003-12-01 | 2005-09-09 | Introgen Therapeutics, Inc. | Use of mda-7 to inhibit infection by pathogenic organisms |
US20080026410A1 (en) * | 2004-12-02 | 2008-01-31 | Antonia Vlahou | Biomarkers for Bladder Cancer |
EP1854882A4 (de) | 2005-03-01 | 2010-09-22 | Wako Pure Chem Ind Ltd | Verfahren zur gewinnung eines subtraktionspolynukleotids |
WO2008073615A2 (en) * | 2006-11-03 | 2008-06-19 | The Trustees Of Columbia University In The City Of New York | N-glycosylation mutant of melanoma differentiation associated gene-7 |
EP2571991A1 (de) | 2010-05-20 | 2013-03-27 | Evolva SA | Verfahren zur herstellung von isoprenoidverbindungen in hefe |
JP6667790B2 (ja) * | 2014-09-19 | 2020-03-18 | 国立大学法人京都大学 | T細胞リンパ腫の検査方法 |
US10980826B2 (en) * | 2015-11-06 | 2021-04-20 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
EP3371221A2 (de) | 2015-11-07 | 2018-09-12 | MultiVir Inc. | Verfahren und zusammensetzungen mit tumorsuppressorgentherapie und immuncheckpoint-blockade zur behandlung von krebs |
WO2018111902A1 (en) | 2016-12-12 | 2018-06-21 | Multivir Inc. | Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases |
KR20200135986A (ko) | 2018-03-19 | 2020-12-04 | 멀티비르 인코포레이티드 | 종양 억제인자 유전자 치료 및 cd122/cd132 작용제를 포함하는 암 치료를 위한 방법 및 조성물 |
WO2021113644A1 (en) | 2019-12-05 | 2021-06-10 | Multivir Inc. | Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0212285A1 (de) * | 1985-07-29 | 1987-03-04 | Arthur A. Gottlieb | Herleitung und Verwendung ausgewählter Genprodukte |
US4876187A (en) * | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
WO1988007585A1 (en) * | 1987-04-02 | 1988-10-06 | Genelabs, Incorporated | Equal-abundance transcript composition and method |
DE3722958A1 (de) * | 1987-07-11 | 1989-01-19 | Heinrich Dr Klefenz | Verfahren zur identifizierung und/oder isolierung spezifischer molekuele bzw. molekuelpopulationen |
US6107023A (en) * | 1988-06-17 | 2000-08-22 | Genelabs Technologies, Inc. | DNA amplification and subtraction techniques |
EP0372524A3 (de) * | 1988-12-07 | 1991-10-09 | The General Hospital Corporation | Verfahren zur Anreicherung und zum Klonen von DNS, das einer Insertion oder einer Deletion entspricht |
WO1991005861A1 (en) * | 1989-10-16 | 1991-05-02 | Genelabs Incorporated | Non-specific dna amplification |
US5183884A (en) | 1989-12-01 | 1993-02-02 | United States Of America | Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
US5302706A (en) | 1991-12-16 | 1994-04-12 | Baylor College Of Medicine | Senescent cell derived inhibitors of DNA synthesis |
US5643761A (en) | 1993-10-27 | 1997-07-01 | The Trustees Of Columbia University In The City Of New York | Method for generating a subtracted cDNA library and uses of the generated library |
US6051376A (en) | 1994-09-30 | 2000-04-18 | The Trustees Of Columbia University In The City Of New York | Uses of mda-6 |
DE69435103D1 (de) * | 1993-10-27 | 2008-07-10 | Univ Columbia | Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung |
US5710137A (en) | 1996-08-16 | 1998-01-20 | The Trustees Of Columbia University In The City Of New York | Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype |
JP2001508652A (ja) | 1996-12-23 | 2001-07-03 | シェーリング コーポレイション | Il10に関連する哺乳動物サイトカイン |
US6190909B1 (en) | 1997-04-17 | 2001-02-20 | Millennium Pharmaceuticals, Inc. | TH2-specific gene |
US6413717B1 (en) | 1998-03-18 | 2002-07-02 | Corixa Corporation | Methods for indentifying anti-cancer agents |
EP1307234B1 (de) | 1999-07-15 | 2008-04-02 | Introgen Therapeutics, Inc. | Methoden zur behandlung von hyperproliferativen krankheiten mit menschlichem mda-7 |
US6511676B1 (en) * | 1999-11-05 | 2003-01-28 | Teni Boulikas | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
US20030082140A1 (en) | 2001-08-20 | 2003-05-01 | Fisher Paul B. | Combinatorial methods for inducing cancer cell death |
US20080026410A1 (en) * | 2004-12-02 | 2008-01-31 | Antonia Vlahou | Biomarkers for Bladder Cancer |
-
1994
- 1994-10-24 DE DE69435103T patent/DE69435103D1/de not_active Expired - Lifetime
- 1994-10-24 EP EP94932000A patent/EP0730659A4/de not_active Withdrawn
- 1994-10-24 CA CA2174354A patent/CA2174354C/en not_active Expired - Fee Related
- 1994-10-24 EP EP03006745A patent/EP1329509A3/de not_active Withdrawn
- 1994-10-24 KR KR1019960702185A patent/KR100355111B1/ko not_active IP Right Cessation
- 1994-10-24 WO PCT/US1994/012160 patent/WO1995011986A1/en active Application Filing
- 1994-10-24 AU AU80883/94A patent/AU695540B2/en not_active Ceased
- 1994-10-24 EP EP05028213A patent/EP1650303B1/de not_active Expired - Lifetime
- 1994-10-24 DK DK05028213T patent/DK1650303T3/da active
- 1994-10-24 JP JP51275495A patent/JP4145953B2/ja not_active Expired - Fee Related
- 1994-10-24 AT AT05028213T patent/ATE397066T1/de not_active IP Right Cessation
-
1998
- 1998-12-23 US US09/221,268 patent/US6720408B2/en not_active Expired - Fee Related
-
2003
- 2003-04-17 US US10/417,827 patent/US7507792B2/en not_active Expired - Fee Related
-
2007
- 2007-05-21 JP JP2007134823A patent/JP4205136B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-23 US US12/409,356 patent/US20090246272A1/en not_active Abandoned
-
2010
- 2010-09-27 US US12/891,235 patent/US20110136224A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1329509A2 (de) | 2003-07-23 |
EP0730659A1 (de) | 1996-09-11 |
KR960706565A (ko) | 1996-12-09 |
ATE397066T1 (de) | 2008-06-15 |
EP1650303A3 (de) | 2006-05-10 |
JP4145953B2 (ja) | 2008-09-03 |
US7507792B2 (en) | 2009-03-24 |
US20110136224A1 (en) | 2011-06-09 |
US6720408B2 (en) | 2004-04-13 |
EP0730659A4 (de) | 1999-03-31 |
WO1995011986A1 (en) | 1995-05-04 |
EP1650303B1 (de) | 2008-05-28 |
US20090246272A1 (en) | 2009-10-01 |
AU8088394A (en) | 1995-05-22 |
CA2174354A1 (en) | 1995-05-04 |
EP1650303A2 (de) | 2006-04-26 |
EP1329509A3 (de) | 2003-10-15 |
JP2007300928A (ja) | 2007-11-22 |
CA2174354C (en) | 2011-03-29 |
US20020183509A1 (en) | 2002-12-05 |
KR100355111B1 (ko) | 2003-03-03 |
JP4205136B2 (ja) | 2009-01-07 |
JPH09507021A (ja) | 1997-07-15 |
DK1650303T3 (da) | 2008-09-08 |
AU695540B2 (en) | 1998-08-13 |
US20030225025A1 (en) | 2003-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69435103D1 (de) | Methode zur Bildung einer subtrahierten cDNA Bank und ihre Verwendung | |
Cregan et al. | Microsatellite fingerprinting and mapping of soybean | |
DE69900949D1 (de) | Dns amplifizierung aus einzelnen zellen | |
ATE382711T1 (de) | Verfahren zur bestimmung des methylierungsgrades von bestimmten cytosinen in genomischer dna im sequenzkontext 5'-cpg-3' | |
DE69837913D1 (de) | Verfahren zur vervielfältigung von nukleinsäure | |
WO1999014375A3 (en) | Dna typing by mass spectrometry with polymorphic dna repeat markers | |
DE60116651D1 (de) | Methode zur amplifizierung und möglicher charakterisierung von nukleinsäuren | |
ATE269908T1 (de) | Methode zur sequenzierung von nukleinsäuren | |
ATE239090T1 (de) | Methode zum generieren von einzelsträngigen dna molekülen | |
WO2001071042A8 (en) | Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof | |
BR0308134A (pt) | análise rápida das variações em um genoma | |
EP1961826A3 (de) | Verfahren zur direkten Sequenzierung von Nukleinsäuren | |
DE60010058D1 (de) | Biochemische reinigungsgeräte mit immobilisierten fangsonden und ihre anwendungen | |
WO2005118847A1 (en) | Detection of target nucleotide sequences using an asymmetric oligonucleotide ligation assay | |
AU769759B2 (en) | Allele frequency differences method for phenotype cloning | |
OA11358A (en) | Primers for obtaining highly informative DNA markers. | |
WO2001029262A3 (en) | Genotyping reagents, kits and methods of use thereof | |
WO2003060160A3 (en) | Verification of fish origin based on nucleic acid pattern recognition | |
ATE278036T1 (de) | Verfahren zur analyse der dna-methylierung unter verwendung von fluoreszenzpolarisation | |
Langö et al. | Simultaneous analysis of STR and VNTR polymorphisms | |
Çakir et al. | Distribution of amplified fragment length polymorphism D1S80 alleles in Turkish population | |
Shi et al. | Allelic frequencies of three XY homologous STR loci in Chinese population |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |